
Clinical endpoint evidence
Endpoint, unit, analysis population, timepoint, estimate and interval stay associated in each row
Editable PPTX · 2 slides · 1 credit
Editable worksheets for clinical evidence, patient pathways, research planning and access discussions. Each file includes a fictional example and a fill-in slide. Downloads require sign-in and 1 credit per complete template file.
Prefer a free sample? Try the three free pharma templates.

Endpoint, unit, analysis population, timepoint, estimate and interval stay associated in each row
Editable PPTX · 2 slides · 1 credit

Subgroup sample size, effect estimate and confidence interval share one axis and reference value
Editable PPTX · 2 slides · 1 credit

Event-time step function, censoring and numbers at risk are derived from the same individual records
Editable PPTX · 2 slides · 1 credit

Same cohort compared across cutoffs with follow-up, maturity and inference status
Editable PPTX · 2 slides · 1 credit

Hierarchical event definitions linked to each arm's exposed population and n/N
Editable PPTX · 2 slides · 1 credit

Variable definition and summary type paired with arm-specific sample sizes
Editable PPTX · 2 slides · 1 credit

Cohort stage, planned dose level, target enrollment, objective and status
Editable PPTX · 2 slides · 1 credit

Assessment rows intersect scheduled visits with baseline and follow-up definitions
Editable PPTX · 2 slides · 1 credit

Nested cohort counts carry stage-specific definitions and denominator retention
Editable PPTX · 2 slides · 1 credit

Marker conditions map to disjoint classes including unknown results
Editable PPTX · 2 slides · 1 credit

Each journey stage links patient task, barrier, support and operational measure
Editable PPTX · 2 slides · 1 credit

Mechanistic hypothesis links assay, observed readout and remaining limitation
Editable PPTX · 2 slides · 1 credit

Indication and stage linked to capability source, reuse scope and remaining gap
Editable PPTX · 2 slides · 1 credit

Indication by region matrix separates submission, review and approval states
Editable PPTX · 2 slides · 1 credit

Evidence question linked to study design, population, measure and deliverable
Editable PPTX · 2 slides · 1 credit

Barrier and affected population linked to action, accountable owner and measure
Editable PPTX · 2 slides · 1 credit

Trajectory by fictional dose with endpoint estimate, interval and observed n
Editable PPTX · 2 slides · 1 credit

Observed pharmacodynamic trajectory aligned with dose and sampling windows
Editable PPTX · 2 slides · 1 credit

Sustained, relapsed and missing outcomes partition the earlier responder cohort
Editable PPTX · 2 slides · 1 credit

Parallel evidence rows retain definition, denominator, timepoint and inference status
Editable PPTX · 2 slides · 1 credit

Domains link severity range, weight and endpoint coverage with explicit scoring rule
Editable PPTX · 2 slides · 1 credit

Treatment setting axis linked to study, regimen, evidence status and next readout
Editable PPTX · 2 slides · 1 credit

Shared backbone and added components mapped to comparator, setting and study objective
Editable PPTX · 2 slides · 1 credit

Cohort-level response onset summary retains responder denominator and follow-up
Editable PPTX · 2 slides · 1 credit

All required conditions combine with AND logic and explicit handling of missing assessments
Editable PPTX · 2 slides · 1 credit

Stage input, output, timing and quality check define each handover
Editable PPTX · 2 slides · 1 credit

Claim, analysis context, limitation and next verification stay linked
Editable PPTX · 2 slides · 1 credit

Support scheme links eligibility, covered cost, exclusion, duration and evidence
Editable PPTX · 2 slides · 1 credit

One participant per bar shows signed change from the same baseline definition
Editable PPTX · 2 slides · 1 credit

One respondent per row links observed duration, event status and observation cutoff
Editable PPTX · 2 slides · 1 credit